PYC Therapeutics Ltd
ASX:PYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
|
A
|
Aecon Group Inc
F:2AE
|
CA |
|
Beneteau SA
F:3GD
|
FR |
|
Covivio SA
F:F5D
|
FR |
|
McGrath RentCorp
NASDAQ:MGRC
|
US |
|
Sabaf SpA
MIL:SAB
|
IT |
|
N
|
Noul Co Ltd
KOSDAQ:376930
|
KR |
|
S
|
Silicon Laboratories Inc
F:LA5
|
US |
|
Macquarie Korea Infrastructure Fund
KRX:088980
|
KR |
|
A
|
Adx Energy Ltd
F:GHU
|
AU |
|
California Nanotechnologies Corp
XTSX:CNO
|
CA |
|
C
|
Corbion NV
XMUN:CSUA
|
NL |
|
A
|
Amass Brands Inc
NASDAQ:AMSS
|
US |
|
C
|
Croda International PLC
DUS:6CMB
|
UK |
|
Royal Gold Inc
NASDAQ:RGLD
|
US |
|
Chariot Ltd
LSE:CHAR
|
UK |
|
S
|
Sunrun Inc
XMUN:3S9
|
US |
|
Latin Metals Inc
OTC:LMSQF
|
CA |
|
Azienda Bresciana Petroli Nocivelli SpA
F:9UZ
|
IT |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
US |
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
BRP Inc
TSX:DOO
|
CA |
Bankruptcy Probability
PYC Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PYC Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
PYC Therapeutics Ltd
ASX:PYC
|
1.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
242B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
135.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PYC Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PYC Therapeutics Ltd has total debt of 268.5k AUD. This includes both short-term (0 AUD) and long-term (268.5k AUD) debt.
You can find a full breakdown on its Balance Sheet.